Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
NSAID; COX-1/2 inhibitor.
InsR and IGF-1R inhibitor.
Smo inhibitor.
Macrocyclic lactone.
Marine toxin; actin polymerization inducer.
Dihydrofolate reductase inhibitor.
Peptide fragment, renin substrate, precursor to...
Flavonoid glycoside found in citrus fruit.
Fatty acid found in dairy products; HDAC inhibi...
β-lactam cephalosporin; penicillin binding pro...
PKC and PKG inhibitor.
Mesalazine derivative, sulfa drug; sepiapterin ...
HIV protease inhibitor.
Imidazothiazole; alkaline phosphatase inhibitor...
Macrolide; peptidyl transferase inhibitor, prot...
Mixture of kavalactones found in Piper methysti...
Carnitine derivative, involved in energy homeos...
ATP-sensitive K+ channel activator, α-adrenerg...
Peptide, substance P analog; NK agonist.
Steroidal alkaloid found in Fritillaria; M2 mAC...